CO4480761A1 - METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS - Google Patents

METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS

Info

Publication number
CO4480761A1
CO4480761A1 CO96056271A CO96056271A CO4480761A1 CO 4480761 A1 CO4480761 A1 CO 4480761A1 CO 96056271 A CO96056271 A CO 96056271A CO 96056271 A CO96056271 A CO 96056271A CO 4480761 A1 CO4480761 A1 CO 4480761A1
Authority
CO
Colombia
Prior art keywords
seq
chemioquine
stem cells
hematopoietic stem
accordance
Prior art date
Application number
CO96056271A
Other languages
Spanish (es)
Inventor
Louis Martin Pelus
Andrew Garrison King
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Priority to CO96056271A priority Critical patent/CO4480761A1/en
Publication of CO4480761A1 publication Critical patent/CO4480761A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USO DE UNA PROTEINA DERIVADA DE UNA QUIMIO- QUINA DE MAMIFERO, SELECCIONADA ENTRE EL GRUPO QUE CONSTA DE (a) GRO@SEQ ID NO: 2, (b) groBETA SEQ ID NO: 3, (c) groGAMA SEQ ID NO: 4; Y (d) KC SEQ ID NO: 1, EN LA PREPARACION DE UN MEDICAMENTO UTIL PARA MOVILIZAR CELULAS TRONCO HEMATOPOYETICAS. USO DE ACUERDO CON LA REIVINDICACION 1, EN EL QUE DICHA QUIMIOQUINA SE SELECCIONA DEL GRUPO QUE CONSTA DE: (a) KC MADURA; (b) LOS AMINOACIDOS 5 A 72 DE SEQ ID NO: 1; (c) UNA PROTEINA QUIMIOQUINA MULTIMERICA QUE COM- PRENDE UNA ASOCIACION DE DOS O MAS DE (a) o (b); Y (d) UNA PROTEINA QUIMIOQUINA MULTIMERICA QUE COM- PRENDE UNA ASOCIACION DE (a) o (b) CON UNA SEGUNDA QUIMIOQUINA. USO DE ACUERDO CON LAS REIVINDICACIONES 1-5, EN EL QUE DICHO MEDICAMENTO SE ADMINISTRA CONJUN- TAMENTE CON UN FACTOR DE CRECIMIENTO U OTRA BIOMO- LECULA REGULADORA HEMATOPOYETICA. 1 USO DE ACUERDO CON LA REIVINDICACION 10, EN EL QUE EL PACIENTE HA RECIBIDO UNA DOSIS DE UN A- GENTE QUIMIOTERAPEUTICO SELECCIONADO, ANTES DEL TRATAMIENTO CON EL MEDICAMENTO; SE RECOGEN LAS CELULAS TRONCO HEMATOPOYETICAS PROCEDENTES DE LA SANGRE PERIFERICA DEL PACIENTE TRATADO; SE ADMI- NISTRA UN AGENTE QUIMIOTERAPEUTICO; Y SE VUELVE A INFUNDIR EL PACIENTE CON LAS CELULAS RECOGIDAS.USE OF A PROTEIN DERIVED FROM A MAMMALIAN CHEMIOQUINE, SELECTED FROM THE GROUP CONSISTING OF (a) GRO @ SEQ ID NO: 3, (b) groBETA SEQ ID NO: 3, (c) groGAMA SEQ ID NO: 4 ; AND (d) KC SEQ ID NO: 1, IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT TO MOBILIZE HEMATOPOIETIC STEM CELLS. USE IN ACCORDANCE WITH CLAIM 1, IN WHICH SUCH CHEMIOQUINE IS SELECTED FROM THE GROUP WHICH CONSISTS OF: (a) KC MATURA; (b) AMINO ACIDS 5 TO 72 OF SEQ ID NO: 1; (c) A MULTIMERICAL CHEMIOKINE PROTEIN COMPRISING AN ASSOCIATION OF TWO OR MORE THAN (a) or (b); AND (d) A MULTIMERICAL CHEMIOQUINE PROTEIN COMPOSING AN ASSOCIATION OF (a) or (b) WITH A SECOND CHEMIOQUINE. USE IN ACCORDANCE WITH CLAIMS 1-5, IN WHICH SUCH MEDICATION IS ADMINISTERED TOGETHER WITH A GROWTH FACTOR OR ANOTHER HEMATOPOYETIC REGULATORY BIOMOLECULA. 1 USE IN ACCORDANCE WITH CLAIM 10, IN WHICH THE PATIENT HAS RECEIVED A DOSE OF A SELECTED CHEMOTHERAPEUTICAL AGENT, BEFORE TREATMENT WITH THE MEDICINAL PRODUCT; THE HEMATOPOIETIC STEM CELLS FROM THE PERIPHERAL BLOOD OF THE TREATED PATIENT ARE COLLECTED; A CHEMOTHERAPEUTICAL AGENT IS ADMITTED; AND THE PATIENT IS INFUSED AGAIN WITH THE COLLECTED CELLS.

CO96056271A 1996-10-24 1996-10-24 METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS CO4480761A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO96056271A CO4480761A1 (en) 1996-10-24 1996-10-24 METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO96056271A CO4480761A1 (en) 1996-10-24 1996-10-24 METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS

Publications (1)

Publication Number Publication Date
CO4480761A1 true CO4480761A1 (en) 1997-07-09

Family

ID=40929744

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96056271A CO4480761A1 (en) 1996-10-24 1996-10-24 METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS

Country Status (1)

Country Link
CO (1) CO4480761A1 (en)

Similar Documents

Publication Publication Date Title
ES2186693T3 (en) COMBINED USE OF HIALURONIC ACID AND THERAPEUTIC AGENTS TO IMPROVE THE THERAPEUTIC EFFECT.
SE9302308L (en) protein Preparation
SE8504945L (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTRACYCLING GYCOSIDES
BG60253B1 (en) HUMAN TISSUE PLASMINOGENIC ACTIVATOR
DE3680368D1 (en) BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIE FACTOR, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS.
ATE62414T1 (en) AGENT FOR THE TREATMENT OF HEART DISEASES.
IS3284A7 (en) Process for the preparation of N1-substituted benzimidazole derivatives for therapeutic use
DK0934424T3 (en) Process for Preparation of a Recombinant Polypeptide, Adding an Inhibitor of Metal-Dependent Proteases or Chymotrypsins to the Cell Culture Medium
ATE277628T1 (en) TREATMENT OF HEMATOPOIETIC CELLS WITH CXCR4 AGONISTS
HUP9602498A2 (en) Pharmaceutical compositions of antimicrobial activity
RU94046426A (en) Pharmaceutical compositions, methods of leukosis treatment, method of stem cell level increase, antagonist c-kit-ligand, nonsense nucleic acid, method of melanoma treatment, method of transfection enhancement, method of gene transfer, method of peripheral blood level increase, method of platelet level increase, method of biological function modification, method of anemia treatment, method of bone marrow implantation improvement, method of bone marrow recovery acceleration, method of leukopenia treatment
DE58901002D1 (en) AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES.
AR002027A1 (en) TRANSDERMIC FORMULATIONS AND PROCESS TO PREPARE THEM.
FI801228A (en) 6-SUBSTITUTES OF 11-ALKYLENE-MORPHANTRIDINES
ATE132187T1 (en) BAT SALIVA PLASMINOGEN ACTIVator VPA-ALPHA 1
ES2107414T3 (en) USE OF HUMAN INTERFERON-BETA FOR THE STIMULATION OF ERYTHROPOYESIS.
NO810480L (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES
CO4480761A1 (en) METHOD FOR MOBILIZING HEMATOPOIETIC STEM CELLS
ES2042529T3 (en) A PROCEDURE FOR PREPARING A COMBINED THERAPEUTIC COMPOSITION OF A FREE RADICALS REMOVAL OR METABOLIC INHIBITOR AND A BIOLOGICALLY ACTIVE PROTEIN.
GB1537047A (en) Eye ointment
HUP9903679A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
ATE2746T1 (en) PIPERIDINE DERIVATIVES OF 4,5-DIALKYL-3-HYDROXYPYRROL-2-CARBONS[UREESTERS, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
ATE12649T1 (en) OPTICALLY ACTIVE DIPEPTIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
ES8303403A1 (en) 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5 diols, process for their preparation, pharmaceutical preparations containing them and their therapeutical use.
ES2165366T3 (en) PROCEDURES AND COMPOSITIONS TO INHIBIT THE INFLAMMATION MEDIATED BY ENDOTELIAL CELLS AND FIBRINOGEN.